SE9904419A
SE9904419D0
(en)
|
1999-12-03 |
1999-12-03 |
New use
|
ARP000101756A
AR023510A1
(en)
|
1999-04-21 |
2000-04-14 |
A TEAM OF PARTS, PHARMACEUTICAL FORMULATION AND USE OF A THROMBIN INHIBITOR.
|
HU0200955A
HUP0200955A3
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
BR0009847-7A
BR0009847A
(en)
|
1999-04-21 |
2000-04-19 |
Kit of parts, method of preparing a kit of parts, pharmaceutical formulation, method of treating a condition in which thrombin inhibition is required or desired, and use of a thrombin inhibitor, or a pharmaceutically acceptable derivative thereof
|
CA002371008A
CA2371008A1
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
NZ514827A
NZ514827A
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
RU2001128157/15A
RU2252783C2
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical preparation containing low-molecular thrombin inhibitor and its pre-medicine
|
AU46336/00A
AU754405B2
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
US09/582,863
US6962905B1
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
PCT/SE2000/000756
WO2000064470A1
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
MYPI20001656A
MY128061A
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
EP00928047A
EP1200118B1
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising megalatran and its prodrug
|
CNB008091447A
CN100377742C
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug
|
TR2001/03017T
TR200103017T2
(en)
|
1999-04-21 |
2000-04-19 |
Formulation with low molecular weight thrombin inhibitor
|
SK1496-2001A
SK14962001A3
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
EEP200100543A
EE200100543A
(en)
|
1999-04-21 |
2000-04-19 |
A dosage form comprising a low molecular weight thrombin inhibitor and a prodrug thereof
|
PT00928047T
PT1200118E
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising megalatran and its prodrug
|
EP07120002A
EP1886691A3
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
SI200030982T
SI1200118T1
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising megalatran and its prodrug
|
DE60037816T
DE60037816T2
(en)
|
1999-04-21 |
2000-04-19 |
PHARMACEUTICAL FORMULATION CONTAINING MEGALATRANE AND ITS PRO-PHARMAKA
|
KR1020017013403A
KR20010110788A
(en)
|
1999-04-21 |
2000-04-19 |
A Pharmaceutical Formulation Comprising a Low Molecular Weight Thrombin Inhibitor and Its Prodrug
|
JP2000613460A
JP2002542298A
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical formulations containing low molecular weight thrombin inhibitors and their prodrugs
|
DK00928047T
DK1200118T3
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical composition comprising megalatran and its prodrug
|
IL14584000A
IL145840A0
(en)
|
1999-04-21 |
2000-04-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
ES00928047T
ES2298141T3
(en)
|
1999-04-21 |
2000-04-19 |
A PHARMACEUTICAL FORMULATION THAT MELAGATRAN AND HIS PROFARMACY UNDERSTAND
|
PL351917A
PL201793B1
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical preparation containing low molecular mass thrombin inhibitor and its agonist
|
AT00928047T
ATE383868T1
(en)
|
1999-04-21 |
2000-04-19 |
PHARMACEUTICAL FORMULATION CONTAINING MEGALATRAN AND ITS PROPHARMACEUTICALS
|
CZ20013757A
CZ20013757A3
(en)
|
1999-04-21 |
2000-04-19 |
Pharmaceutical composition containing thrombin inhibitor of low molecular weight and precursor thereof
|
SA00210092A
SA00210092B1
(en)
|
1999-04-21 |
2000-05-15 |
A pharmaceutical formulation that includes a thrombin inhibitor of low molecular weight
|
IS6111A
IS6111A
(en)
|
1999-04-21 |
2001-10-19 |
A pharmaceutical composition comprising a low molecular weight thrombin inhibitor and its prodrug
|
NO20015107A
NO20015107D0
(en)
|
1999-04-21 |
2001-10-19 |
A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
|
HK02107166.1A
HK1045465B
(en)
|
1999-04-21 |
2002-09-27 |
A pharmaceutical formulation comprising megalatran and its prodrug
|
US11/206,006
US20060009397A1
(en)
|
1999-04-21 |
2005-08-18 |
New use
|
US11/979,882
US20080113960A1
(en)
|
1999-04-21 |
2007-11-09 |
Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor
|